1 |
Aalen, O. O. (1988). Heterogeneity in survival analysis, statistics in Mediciene, 7, 1121-1137.
DOI
ScienceOn
|
2 |
Andersen, P. K. and Gill, R. D. (1982). Cox' Regression model for counting processes: A large sample study, The Annals of Statistics, 10, 1100-1120.
DOI
|
3 |
Cox, D. R. (1972). Regression models and life-tables(with discussion), Journal of the Royal Statistical Society. Series B, 34, 187-220.
|
4 |
Duchateau, L., Janssen, P., Lindsey, P., Legrand, C., Nguti, R. and Sylvester, R. (2002). The shared frailty model and the power for heterogeneity tests in multicenter trials, Computational Statistics & Data Analysis, 40, 603-620.
DOI
ScienceOn
|
5 |
Klein, J. P. (1992). Semiparametric estimation of random effects using the Cox model based on the EM algorithm, Biomertrics, 48, 795-806.
DOI
ScienceOn
|
6 |
Therneau, T. M. and Grambsch, P. M. (2000). Modeling Survival Data-Extending the Cox Model, Springer, New York.
|
7 |
Clayton, D. G. (1978). A model for association in bivariate life tables and its application in epidemilological studies of familial tendency in chronic disease incidence, Biometrika, 65, 141-151.
DOI
ScienceOn
|
8 |
Halloran, M. E., Longini, I. M. Jr. and Stauchiner, C. J. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models, American Journal of Epidemiology, 144, 83-97.
DOI
ScienceOn
|
9 |
Box-Steffensmeier, J. M. and De Boef, S. (2006). Repeated events survival models: The conditional frailty model, Statistics in Medicine, 25, 3518-3533.
DOI
ScienceOn
|
10 |
Greenwood, M. and Yule, U. G. (1915). The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general, Proceedings of the Royal Society of Medicine, 8, 113-194.
|
11 |
Gutierrez, R. G. (2002). Parametric frailty and shared frailty survival modes, The Stata Journal, 2, 22-44.
|
12 |
Halloran, M. E., Haber, M. and Longini, I. M. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity, American Journal of Epidemiology, 136, 328-343.
DOI
|
13 |
Zeger, S. L. and Liang, L. (1986). Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121-130.
DOI
ScienceOn
|
14 |
Brunet, R. C., Struchiner, C. J. and Halloran, M. E. (1993). On the distribution of vaccine protection under heterogeneous response, Mathematical Biosciences, 116, 111-125.
DOI
ScienceOn
|
15 |
Klein, J. P. and Moeschberger, L. M. (1997). Survival Analysis-Techniques for Censored and Truncated Data, Springer, New York.
|
16 |
Longini, I. M., Halloran, M. E. and Harber, M. (1993). Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity, Mathematical Biosciences, 117, 271-281.
DOI
ScienceOn
|
17 |
Liang, K. and Zeger, S. (1986). Longitudinal data analysis using generalized linear model, Biometrika, 73, 13-22.
DOI
ScienceOn
|
18 |
Hougaard, P. (2000). Analysis of Multivariate Survival Data, Springer, New York.
|
19 |
Wei, L. J., Lin, D. Y. and Weissfeld, L. (1989). Regression analysis of multivariate incomplete failure time data by modeling marginal distributions, Journal of the American Statistical Association, 84, 1065-1073.
DOI
ScienceOn
|
20 |
Valim, C., Mezzetti, M., Maguire, J., Urdaneta, M. and Wypij, D. (2008). Estimation of vaccine efficacy in a repeated measures study under heterogeneity of exposure or susceptibility to infecton, Philosophical Transactions of the Royal society A: Mathematical, Physical and Engineering Sciences, 366, 2347-2360.
DOI
ScienceOn
|